PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
153 hedge funds and large institutions have $341M invested in Progenics Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
42% less call options, than puts
Call options by funds: $1.37M | Put options by funds: $2.36M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
153
Holding in Top 10
–
Calls
$1.37M
Puts
$2.36M
Top Buyers
| 1 | +$1.21M | |
| 2 | +$802K | |
| 3 | +$619K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$609K |
| 5 |
JPMorgan Chase & Co
New York
|
+$527K |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$2.56M | |
| 3 | -$2.1M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.97M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.79M |